➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Medtronic
McKinsey
Merck

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs Containing Excipient (Inactive Ingredient) CARMINIC ACID


Email this page to a colleague

« Back to Dashboard

Branded drugs containing CARMINIC ACID excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
AbbVie Inc. ORILISSA elagolix 0074-0038 CARMINIC ACID 2024-09-10
Novartis Pharmaceuticals Corporation RYDAPT rydapt 0078-0698 CARMINIC ACID 2024-04-28
Vertex Pharmaceuticals Incorporated ORKAMBI lumacaftor and ivacaftor 51167-809 CARMINIC ACID 2030-12-11
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Generic drugs containing CARMINIC ACID excipient

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
McKinsey
Baxter
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.